121 related articles for article (PubMed ID: 36706325)
1. Anticholinergic Drug Burden and Risk of Incident MCI and Dementia: A Population-based Study.
Gildengers A; Stoehr GP; Ran X; Jacobsen E; Teverovsky E; Chang CH; Ganguli M
Alzheimer Dis Assoc Disord; 2023 Jan-Mar 01; 37(1):20-27. PubMed ID: 36706325
[TBL] [Abstract][Full Text] [Related]
2. Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults.
Weigand AJ; Bondi MW; Thomas KR; Campbell NL; Galasko DR; Salmon DP; Sewell D; Brewer JB; Feldman HH; Delano-Wood L;
Neurology; 2020 Oct; 95(16):e2295-e2304. PubMed ID: 32878992
[TBL] [Abstract][Full Text] [Related]
3. Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
Green AR; Reifler LM; Boyd CM; Weffald LA; Bayliss EA
Drugs Aging; 2018 Mar; 35(3):223-232. PubMed ID: 29404965
[TBL] [Abstract][Full Text] [Related]
4. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.
Campbell NL; Lane KA; Gao S; Boustani MA; Unverzagt F
Pharmacotherapy; 2018 May; 38(5):511-519. PubMed ID: 29600808
[TBL] [Abstract][Full Text] [Related]
6. Benzodiazepine use and risk of incident MCI and dementia in a community sample.
Teverovsky EG; Gildengers A; Ran X; Jacobsen E; Chang CH; Ganguli M
Int Psychogeriatr; 2024 Feb; 36(2):142-148. PubMed ID: 37231775
[TBL] [Abstract][Full Text] [Related]
7. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis.
Pieper NT; Grossi CM; Chan WY; Loke YK; Savva GM; Haroulis C; Steel N; Fox C; Maidment ID; Arthur AJ; Myint PK; Smith TO; Robinson L; Matthews FE; Brayne C; Richardson K
Age Ageing; 2020 Oct; 49(6):939-947. PubMed ID: 32603415
[TBL] [Abstract][Full Text] [Related]
8. Mild polypharmacy and MCI progression in older adults: the mediation effect of drug-drug interactions.
Trevisan C; Limongi F; Siviero P; Noale M; Cignarella A; Manzato E; Sergi G; Maggi S
Aging Clin Exp Res; 2021 Jan; 33(1):49-56. PubMed ID: 31758500
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergic Burden and Functional Status in Older People with Cognitive Impairment: Results from the Regal Project.
Boccardi V; Baroni M; Paolacci L; Ercolani S; Longo A; Giordano M; Ruggiero C; Mecocci P
J Nutr Health Aging; 2017; 21(4):389-396. PubMed ID: 28346565
[TBL] [Abstract][Full Text] [Related]
10. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
[TBL] [Abstract][Full Text] [Related]
11. Anticholinergic medications and risk of dementia in older adults: Where are we now?
Chatterjee S; Talwar A; Aparasu RR
Expert Opin Drug Saf; 2020 Oct; 19(10):1251-1267. PubMed ID: 32797761
[TBL] [Abstract][Full Text] [Related]
12. APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.
Qian J; Wolters FJ; Beiser A; Haan M; Ikram MA; Karlawish J; Langbaum JB; Neuhaus JM; Reiman EM; Roberts JS; Seshadri S; Tariot PN; Woods BM; Betensky RA; Blacker D
PLoS Med; 2017 Mar; 14(3):e1002254. PubMed ID: 28323826
[TBL] [Abstract][Full Text] [Related]
13. Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study.
Pasina L; Lucca U; Tettamanti M
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1696-1702. PubMed ID: 33098318
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales.
Novella A; Elli C; Ianes A; Pasina L
Drugs Aging; 2023 Nov; 40(11):1017-1026. PubMed ID: 37620654
[TBL] [Abstract][Full Text] [Related]
15. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
[TBL] [Abstract][Full Text] [Related]
16. Is Ongoing Anticholinergic Burden Associated With Greater Cognitive Decline and Dementia Severity in Mild to Moderate Alzheimer's Disease?
Dyer AH; Murphy C; Segurado R; Lawlor B; Kennelly SP;
J Gerontol A Biol Sci Med Sci; 2020 Apr; 75(5):987-994. PubMed ID: 31613323
[TBL] [Abstract][Full Text] [Related]
17. Long-term anticholinergic use and the aging brain.
Cai X; Campbell N; Khan B; Callahan C; Boustani M
Alzheimers Dement; 2013 Jul; 9(4):377-85. PubMed ID: 23183138
[TBL] [Abstract][Full Text] [Related]
18. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
[TBL] [Abstract][Full Text] [Related]
19. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal.
Roberts RO; Knopman DS; Mielke MM; Cha RH; Pankratz VS; Christianson TJ; Geda YE; Boeve BF; Ivnik RJ; Tangalos EG; Rocca WA; Petersen RC
Neurology; 2014 Jan; 82(4):317-25. PubMed ID: 24353333
[TBL] [Abstract][Full Text] [Related]
20. Cumulative health deficits,
Ward DD; Wallace LMK; Rockwood K
J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):136-142. PubMed ID: 33188132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
